Previous Close | 0.5100 |
Open | 0.5000 |
Bid | 0.0000 |
Ask | 0.7000 |
Strike | 10.00 |
Expire Date | 2024-12-20 |
Day's Range | 0.5000 - 0.5900 |
Contract Range | N/A |
Volume | |
Open Interest | 13 |
BRIDGEWATER, N.J., June 05, 2024--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") today announced the continued expansion of its injectables portfolio with six new injectable product launches during the second quarter of 2024, bringing the Company’s total number of commercial injectable products available for the U.S. institutional market to over 40.
BRIDGEWATER, N.J., May 22, 2024--Amneal to Participate at Upcoming Investor Conference
BRIDGEWATER, N.J., May 22, 2024--Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California